Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Pulmonary Embolism Clinical Trials
Pulmonary Embolism clinical trials are recruiting across 194 cities. Here are the cities with the most active studies:
Pulmonary Embolism Trial Phases
85 research organizations are sponsoring pulmonary embolism trials.
About Pulmonary Embolism
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
Clinical trials are advancing new treatments for pulmonary embolism. Currently, 100 studies are recruiting a combined 685,214 participants across the United States. Research is being conducted by 85 organizations including Stanford University, Columbia University, University of South Florida and 82 others.
2026 Pulmonary Embolism Research Landscape
As of July 2026, the pulmonary embolism clinical trial landscape includes 100 actively recruiting studies across 194 cities in the United States. These studies are collectively seeking 685,214 participants, with an average enrollment target of 6,852 per study.
The research spans multiple phases of development: 24 studies are in NA, 16 studies are in PHASE3, 4 studies are in PHASE4, 3 studies are in PHASE2, 1 study is in PHASE1. The presence of Phase 3 trials indicates that some pulmonary embolism treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 85 different organizations, including Stanford University, Columbia University, University of South Florida, University of Central Florida, Sanford Health, and 80 others. The large number of sponsors reflects significant research interest and investment in pulmonary embolism treatment advancement.
Geographically, pulmonary embolism trials are most concentrated in Los Angeles, California (17 trials); Boston, Massachusetts (13 trials); Birmingham, Alabama (13 trials); Phoenix, Arizona (10 trials); Aurora, Colorado (9 trials) and 7 other cities.
Featured Pulmonary Embolism Studies
Highlighted recruiting studies for pulmonary embolism, selected by enrollment size and research scope.
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will be enrolled to participate in the iPATH transformation in their clinic and will participate in quali...
Genomic Uniformed-Screening Against Rare Disease In All Newborns
The goal of this study is to learn how genomic sequencing technology can be used to effectively expand the conditions screened on newborn screening. Newborn screening ensures equity and allows all babies to have the same chance at the healthiest life. Families will be invited to have their newborn baby screened for additional conditions beyond what all babies are screened for as part of the newbor...
TrialNet Pathway to Prevention of T1D
Rationale: The accrual of data from the laboratory and from epidemiologic and prevention trials has improved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Genetic and immunologic factors play a key role in the development of T1DM, and characterization of the early metabolic abnormalities in T1DM is steadily increasing. However, information regarding the na...
Frequently Asked Questions About Pulmonary Embolism Clinical Trials
Are there pulmonary embolism clinical trials near me?
Yes, there are 100 pulmonary embolism clinical trials currently recruiting across 194+ cities in the United States, including Los Angeles, California; Boston, Massachusetts; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.
How do I join a pulmonary embolism clinical trial?
To join a pulmonary embolism clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are pulmonary embolism clinical trials free?
Yes, participation in pulmonary embolism clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of pulmonary embolism treatments are being studied?
Current pulmonary embolism clinical trials are testing a range of approaches across NA (24 studies), PHASE3 (16 studies), PHASE4 (4 studies), PHASE2 (3 studies), PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 85 research organizations.
Is it safe to participate in pulmonary embolism clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov